eli lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
Published 3 weeks ago • 5.6K plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
7:14
eli lilly ceo david ricks on q3 results: the underlying growth story is fantastic
-
3:58
eli lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance.
-
5:27
eli lilly's drop after earnings is a buying opportunity, says mizuho's jared holz
-
0:59
eli lilly ceo on why food companies haven't seen a big impact on sales
-
3:45
three-stock lunch: eli lilly, transdigm, & nvidia
-
10:13
jim cramer looks at the market's response to trump's treasury pick
-
5:10
dow notches record close, russell 2000 hits all time high
-
4:12
'fast money' traders talk the upcoming slate of retail earnings
-
9:35
eli lilly's miss explanation is 'totally opaque', says jim cramer
-
0:55
eli lilly ceo on compounded versions of weight loss drugs
-
1:47
eli lilly results top estimates on mounjaro strength but slashes full-year profit outlook
-
1:54
eli lilly blows past estimates, hikes guidance as zepbound, mounjaro sales soar
-
4:12
eli lilly ceo david ricks explains q1 earnings miss, lowered forecast
-
1:38
chart of the day: eli lilly
-
3:31
call of the day: eli lilly
-
0:41
jim cramer on the huge potential for eli lilly's answer to ozempic #shorts
-
0:54
how eli lilly’s insulin price cut affects big pharma
-
6:43
eli lilly ceo on weight loss drugs outlook: our top priority is making more product
-
0:36
eli lilly’s affordable weight loss breakthrough
-
2:14
eli lilly cuts insulin prices by 70%
-
3:53
eli lilly's alzheimer drug is 'a nice additional therapy', says mizuho's jared holz
-
4:39
eli lilly ceo reacts to q3 earnings miss, provides pipeline update